Long-term Follow-up of Subjects Treated With CARv3-TEAM-E T Cells
Condition(s):Glioblastoma Recurrent, EGFR vIII Mutant; Newly Diagnosed Glioblastoma, EGFRvIII Mutant; Recurrent Glioblastoma, EGFR vIII NegativeLast Updated:August 27, 2021Not yet recruiting